Wrist surgery pain relief showdown: which block works best?
NCT ID NCT07665762
First seen Jun 24, 2026 · Last updated Sep 09, 2026 · Updated 3 times
Summary
This study tests two ways to numb the arm for wrist fracture surgery in people at high risk for severe pain. One method uses a long-acting numbing drug (liposomal bupivacaine) plus regular bupivacaine, and the other uses a steroid (dexamethasone) plus regular bupivacaine. The goal is to see which provides better pain control in the first 48 hours after surgery. About 90 adults with risk factors like severe pre-surgery pain or anxiety will take part.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Liposomal bupivacaine and dexamethasone
- What this could lead to
- If successful, this could show that one pain-block method works better for high-risk patients, helping doctors choose the most effective and cost-efficient option.
- What could go wrong
- This is a small, early-stage trial with only 90 participants, so results may not apply to everyone. The difference between treatments might be small or not clinically meaningful.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 3
Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.
- Participants
-
About 90 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Aug 2026
- Expected to finish
-
Mar 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 90 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * American Society of Anesthesiologist (ASA) status I-III * Age 18-90 years old * Scheduled for distal radial fracture fixation (Open reduction and internal fixation with volar approaching locking plate) * Informed consent obtained * Patients identified to be at an elevated risk of suffering from poor postoperative pain control. Patients with one or more of the following risk factors: * Severe preoperative pain: defined as worse numerical rating scale (NRS) pain score equal or higher than 6/10 with arm movements at day before surgery. * Preoperative use of opioid: use of strong opioids such as morphine, oxycodone * Depressive symptoms: Patient health questionnaire (PHQ-9) score of 10 or above * Anxiety symptoms: General Anxiety Disorder (GAD-7) score of 10 or above * Higher energy and high-grade fracture cases - road traffic accident, fall from height, open fractures, combined distal radius and distal ulna fractures, fractures requiring external fixation, fractures with severe articular comminution or severe metaphyseal extension, comminuted fractures requiring more than a single volar approach incision and a single volar locking plate implant Exclusion Criteria: * Revision surgery * Previous fractures or surgery in the affected distal radius * Surgery involving more than the affected arm * Cases with baseline (pre-injury) QuickDASH score worse (higher) than 10 out of 100 * Respiratory compromise (requires long term oxygen) * History of seizures * Pre-existing neurological disorder/deficit * Alcohol or substance abuse * Impaired mental state * Local infection * Allergy to analgesic drugs: local anaesthetic drugs, paracetamol, non-steroidal anti-inflammatory drugs (NSAIDs), opioids * Impaired renal function (defined as effective glomerular filtration rate \< 30ml/min/1.73m2 * Impaired liver function (defined as plasma bilirubin over 34μmol/L; international normalized ratio \[INR\] ≥1.7, alanine aminotransferase \[ALT\] over 100U/L, aspartate aminotransferase \[AST\] over 100U/L) * Coagulopathy (platelet count \<100,000/ml and/or INR ≥ 1.5) or the use of anticoagulants (not including aspirin) that precludes the use of supraclavicular BPB * Pregnancy * Patient refusal for regional nerve blocks * Patient refusal to join the clinical trial * Patient unable/unwilling to attend post-op rehabilitation programme
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Dexamethasone are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Queen Mary Hospital
RECRUITINGHong Kong, Hong Kong
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Three ways to block hernia surgery pain go head to head
- Could a small electrical device cut painkiller use after hip surgery?
- Can a common steroid stretch spinal anesthesia and keep surgery patients comfortable longer?
- Can a blood pressure drug cut opioid needs during bowel surgery?
- Can a Nerve-Blocking injection prevent salivary complications after parotid surgery?
- Two nerve blocks go head to head for breast surgery pain